This compound is primarily utilized in the synthesis of chiral intermediates for pharmaceuticals, particularly in the development of drugs that require specific enantiomeric forms for enhanced efficacy and reduced side effects. It serves as a key building block in the production of active pharmaceutical ingredients (APIs) for treatments targeting central nervous system disorders, cardiovascular diseases, and certain types of cancer. Additionally, it is employed in asymmetric catalysis to facilitate the creation of complex molecules with high enantioselectivity, which is crucial in fine chemical and agrochemical manufacturing. Its role in research and development also extends to the study of receptor-ligand interactions, aiding in the discovery of novel therapeutic agents.